These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 9864170

  • 1. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system.
    Dai J, Weinberg RS, Waxman S, Jing Y.
    Blood; 1999 Jan 01; 93(1):268-77. PubMed ID: 9864170
    [Abstract] [Full Text] [Related]

  • 2. Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis.
    Kitamura K, Minami Y, Yamamoto K, Akao Y, Kiyoi H, Saito H, Naoe T.
    Leukemia; 2000 Oct 01; 14(10):1743-50. PubMed ID: 11021749
    [Abstract] [Full Text] [Related]

  • 3. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia.
    Cai X, Shen YL, Zhu Q, Jia PM, Yu Y, Zhou L, Huang Y, Zhang JW, Xiong SM, Chen SJ, Wang ZY, Chen Z, Chen GQ.
    Leukemia; 2000 Feb 01; 14(2):262-70. PubMed ID: 10673743
    [Abstract] [Full Text] [Related]

  • 4. Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine.
    Wu XX, Ogawa O, Kakehi Y.
    Int J Oncol; 2004 Jun 01; 24(6):1489-97. PubMed ID: 15138592
    [Abstract] [Full Text] [Related]

  • 5. [Study on the resveratrol and arsenic trioxide combination induced apoptosis and its mechanism on lung adenocarcinoma cells].
    Gu S, Chen C, Jiang X, Zhang Z.
    Wei Sheng Yan Jiu; 2016 Jan 01; 45(1):87-92. PubMed ID: 26987203
    [Abstract] [Full Text] [Related]

  • 6. The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms.
    Zhang W, Ohnishi K, Shigeno K, Fujisawa S, Naito K, Nakamura S, Takeshita K, Takeshita A, Ohno R.
    Leukemia; 1998 Sep 01; 12(9):1383-91. PubMed ID: 9737686
    [Abstract] [Full Text] [Related]

  • 7. Arsenic-induced apoptosis in malignant cells in vitro.
    Akao Y, Yamada H, Nakagawa Y.
    Leuk Lymphoma; 2000 Mar 01; 37(1-2):53-63. PubMed ID: 10721769
    [Abstract] [Full Text] [Related]

  • 8. Role of GSTP1-1 in mediating the effect of As2O3 in the Acute Promyelocytic Leukemia cell line NB4.
    Bernardini S, Nuccetelli M, Noguera NI, Bellincampi L, Lunghi P, Bonati A, Mann K, Miller WH, Federici G, Lo Coco F.
    Ann Hematol; 2006 Oct 01; 85(10):681-7. PubMed ID: 16733740
    [Abstract] [Full Text] [Related]

  • 9. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations.
    Zhu XH, Shen YL, Jing YK, Cai X, Jia PM, Huang Y, Tang W, Shi GY, Sun YP, Dai J, Wang ZY, Chen SJ, Zhang TD, Waxman S, Chen Z, Chen GQ.
    J Natl Cancer Inst; 1999 May 05; 91(9):772-8. PubMed ID: 10328107
    [Abstract] [Full Text] [Related]

  • 10. [Arsenic trioxide combined with buthionine sulfoximine enhances apoptosis in multidrug-resistant human leukemia K562/ADM cells in vitro].
    Wang T, Ma LM, Zhang HP, Wang HW, Yang LH, Qiao ZH.
    Zhonghua Zhong Liu Za Zhi; 2008 Mar 05; 30(3):188-91. PubMed ID: 18756933
    [Abstract] [Full Text] [Related]

  • 11. Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice.
    Kinjo K, Kizaki M, Muto A, Fukuchi Y, Umezawa A, Yamato K, Nishihara T, Hata J, Ito M, Ueyama Y, Ikeda Y.
    Leukemia; 2000 Mar 05; 14(3):431-8. PubMed ID: 10720138
    [Abstract] [Full Text] [Related]

  • 12. In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins.
    Chen GQ, Zhu J, Shi XG, Ni JH, Zhong HJ, Si GY, Jin XL, Tang W, Li XS, Xong SM, Shen ZX, Sun GL, Ma J, Zhang P, Zhang TD, Gazin C, Naoe T, Chen SJ, Wang ZY, Chen Z.
    Blood; 1996 Aug 01; 88(3):1052-61. PubMed ID: 8704214
    [Abstract] [Full Text] [Related]

  • 13. Differential augmentative effects of buthionine sulfoximine and ascorbic acid in As2O3-induced ovarian cancer cell death: oxidative stress-independent and -dependent cytotoxic potentiation.
    Ong PS, Chan SY, Ho PC.
    Int J Oncol; 2011 Jun 01; 38(6):1731-9. PubMed ID: 21455570
    [Abstract] [Full Text] [Related]

  • 14. Arsenic trioxide-induced apoptosis of Hep-2 cell line through modulating intracellular glutathione (GSH) level.
    Cheng B, Yang X, An L, Gao B, Liu X.
    Auris Nasus Larynx; 2010 Feb 01; 37(1):89-94. PubMed ID: 19574005
    [Abstract] [Full Text] [Related]

  • 15. [The relationship between sensitivity to arsenic trioxide and antioxidative capacity of malignant hematopoietic cells].
    Zhu Q, Chen G, Huang Y.
    Zhonghua Zhong Liu Za Zhi; 2000 Sep 01; 22(5):359-61. PubMed ID: 11778267
    [Abstract] [Full Text] [Related]

  • 16. Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARalpha independent manner.
    Wang ZG, Rivi R, Delva L, König A, Scheinberg DA, Gambacorti-Passerini C, Gabrilove JL, Warrell RP, Pandolfi PP.
    Blood; 1998 Sep 01; 92(5):1497-504. PubMed ID: 9716575
    [Abstract] [Full Text] [Related]

  • 17. Dual effects of arsenic trioxide (As2O3) on non-acute promyelocytic leukaemia myeloid cell lines: induction of apoptosis and inhibition of proliferation.
    Rojewski MT, Baldus C, Knauf W, Thiel E, Schrezenmeier H.
    Br J Haematol; 2002 Mar 01; 116(3):555-63. PubMed ID: 11849211
    [Abstract] [Full Text] [Related]

  • 18. Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine.
    Maeda H, Hori S, Ohizumi H, Segawa T, Kakehi Y, Ogawa O, Kakizuka A.
    Cell Death Differ; 2004 Jul 01; 11(7):737-46. PubMed ID: 15002036
    [Abstract] [Full Text] [Related]

  • 19. A novel differentiation-inducing therapy for acute promyelocytic leukemia with a combination of arsenic trioxide and GM-CSF.
    Muto A, Kizaki M, Kawamura C, Matsushita H, Fukuchi Y, Umezawa A, Yamada T, Hata J, Hozumi N, Yamato K, Ito M, Ueyama Y, Ikeda Y.
    Leukemia; 2001 Aug 01; 15(8):1176-84. PubMed ID: 11480559
    [Abstract] [Full Text] [Related]

  • 20. The effects of arsenic trioxide (As2O3) on human megakaryocytic leukemia cell lines. With a comparison of its effects on other cell lineages.
    Alemany M, Levin J.
    Leuk Lymphoma; 2000 Jun 01; 38(1-2):153-63. PubMed ID: 10811458
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.